coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Ormskirk PCN, West Lancashire · Health Inequalities Profile

    PCN U21757 · NHS Lancashire and South Cumbria Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    30,505

    Registered population

    56.3% aged 18–64

    27.1%

    Aged 65+

    ICB 20.0% · England 17.9%

    3.4%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    5,383

    Hypertension register

    +3.82% in 3 yrs · England +5.60%

    233

    SMI register

    21.8% of West Lancashire's

    538

    COPD register

    Reviews +21.35% in 3 yrs

    Forecast to 2030

    5,988

    Hypertension patients, 2030

    +605 on today

    54.4%

    QRISK ≥20% on statins, 2030

    +1.53pp over 3 yrs

    6.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    51.2%
    High-risk lipid therapy trails comparators.

    Only 51.2% of patients with QRISK ≥ 20% receive lipid-lowering therapy (England 63.6%), alongside 66.3% hypertension control (West Lancashire 74.1%), which may reflect titration.

    63.8%
    Asthma and SMI reviews lag borough.

    Asthma annual reviews sit at 63.8% (leaving about 750 unreviewed) and SMI blood pressure checks at 77.5% (West Lancashire 84.9%), suggesting recall gaps.

    95.5%
    Age-five vaccination exceeds 95.0% target.

    MMR dose 2 and 4-in-1 booster coverage at age 5 both reach 95.5% in Q1 2025/26, surpassing England (82.8% and 80.9%) and the 95.0%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    An older population with 27.1% aged 65+ could drive higher primary care demand

    Ormskirk PCN has 30,505 registered patients. Service planning is shaped by an older demographic: 27.1% (8,274 patients) are aged 65+, compared to 22.8% in West Lancashire, 20.0% in the ICB, and 17.9% in England. Those aged 18-64 represent 56.3% (17,169 patients; West Lancashire 59.3%, ICB 60.4%, England 62.7%), and aged 0-17 represent 16.6% (5,062 patients; West Lancashire 17.9%, ICB 19.6%, England 19.6%). Census usual-resident ethnicity shows 96.6% White (West Lancashire 96.9%, ICB 87.8%, England 81.1%) and a 3.4% non-White ethnic minority share (Asian 1.4%, Mixed 1.4%, Black 0.4%, Other 0.2%).

    Age profile

    0–1716.6%
    18–6456.3%
    65+27.1%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White96.6%
    Mixed1.4%
    Asian1.4%
    Black0.4%
    Other0.2%

    Older people · falls rows are West Lancashire local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (West Lancashire LA)2,0162,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.7%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.7%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (West Lancashire LA)9951,0219552024/25
    Falls deaths, all ages, per 100,000 (West Lancashire LA)11.318.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is low across Ormskirk PCN, with zero registered patients in Core20 areas

    Ormskirk PCN records an average IMD decile of 7.8, compared to 6.2 in West Lancashire, 5.0 in the ICB, and 5.5 in England. Across the PCN, 0.0% of registered patients live in Core20 areas (West Lancashire 16.3%, ICB 30.6%, England 21.0%), yielding 0 estimated Core20 patients. However, area-level affluence can mask clinical vulnerability: among 233 patients on the severe mental illness register, blood pressure checks reach 77.5% (West Lancashire 84.9%, England 83.4%). Place-based Core20 outreach will not address local inequalities, so the PCN should target condition-specific clinical cohorts.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Ormskirk Medical0.0% · 0 patients
    Parkgate0.0% · 0 patients
    Elms0.0% · 0 patients
    Aughton0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    233

    SMI register

    0.77% recorded prevalence

    114

    Learning disability register

    0.38% recorded prevalence

    13

    Care homes, 652 beds

    In the PCN catchment

    10.0%

    Provide unpaid care

    West Lancashire, Census 2021

    Inclusion-health registers record 233 severe mental illness patients (0.8% vs West Lancashire 0.9%, ICB 1.2%, England 1.0%) and 114 learning disability patients (0.4% vs West Lancashire 0.5%, ICB 0.6%, England 0.6%). The PCN catchment includes 13 care homes with 652 beds. Borough data records 10.0% unpaid care and 9 rough sleepers, which cannot be extrapolated to PCN lists.

    Severe mental illness: physical health checks

    SMI physical health checks trail West Lancashire: blood pressure recording is 77.5% (vs 84.9%), BMI is 75.0% (vs 84.0%), and alcohol status is 70.5% (vs 83.7%). Lower recording could indicate systematic recall gaps, testable by register audit.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,383

    Hypertension register

    +3.82%

    Register growth, 3 yrs

    West Lancashire +5.26% · England +5.60%

    +1.99pp

    BP control, under 80

    ≤140/90 · +5.49pp aged 80+

    +605

    More patients by 2030

    Forecast 5,988 (19.12%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 17.7% (5,383 patients), compared with 18.2% in West Lancashire, 17.2% in the ICB, and 15.2% in England. While 87.4% of patients have a recent blood pressure reading (West Lancashire 90.1%, England 90.0%), treatment to target is 66.3% (West Lancashire 74.1%, England 70.3%). In patients aged under 80, control to <= 140/90 mmHg is 61.7% (West Lancashire 71.1%, England 67.8%), dropping to 53.1% at Ormskirk Medical Practice. Lower blood pressure control compared with West Lancashire and England may indicate review or titration gaps, which clinical audits could test.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy stand at 51.2%, behind West Lancashire (58.0%) and England (63.6%). Among patients with CKD, therapy coverage is 60.6% against 70.3% nationally. Trailing national lipid coverage could leave high-risk cohorts under-protected, which targeted therapy reviews could test.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202653,202£1.70£1.64£1.86£90,443
    Cardiovascular (all), 202587,175£4.37£3.38£3.33£380,955

    In 2026, lipid-modifying drugs cost £1.70 per item across 53,202 items, compared with £1.75 in West Lancashire, £1.64 in the ICB, and £1.86 in England. PCN spend was £8,512 less than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +21.22%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.37%

    Asthma prevalence, PCN 3-yr % change

    Recorded asthma prevalence is 7.2% (2,070 patients), with annual reviews at 63.8% (West Lancashire 70.0%, England 65.7%), leaving about 750 patients unreviewed despite a 3-year relative increase of +21.2% (England +4.4%). Asthma management prescribing for ages 5-19 is 1,995 items per 1,000 (England 1,488). COPD prevalence is 1.8% (538 patients), where 12-month reviews rose +21.4% to 79.0% (West Lancashire 83.4%, England 76.4%). Slower review completion alongside elevated youth prescribing could indicate routine monitoring gaps, which clinical audits could test.

    Cancer register and children's immunisation

    Cancer QOF prevalence is 5.4% (1,641 patients), exceeding West Lancashire (4.7%) and England (3.8%). In childhood immunisations (Q1 2025/26), 12-month 6-in-1 coverage is 91.2% (ICB 90.3%, England 91.0%), below the 95.0% target by 3.8 pp. By age 5, MMR dose 1 reaches 100.0% while dose 2 is 95.5% (a 4.5 pp difference). Timely first-year primary vaccination requires focused attention.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.2%

    England 91.0%

    6-in-1 complete primary course at 24 months96.4%

    England 92.2%

    MMR dose 1 at 24 months96.4%

    England 88.3%

    MMR dose 2 at age 595.5%

    England 82.8%

    4-in-1 pre-school booster at age 595.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of staged cancers across NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2 (4,642 of 8,863 known-stage cancers; not published at PCN level), trailing England (55.3%) and 22.6 pp below the 75.0% national ambition. Known stage was recorded for 74.6% of registered cancers (8,863 of 11,883). Reaching the 75.0% ambition requires about 2,010 additional early-stage diagnoses annually across the ICB, where early-stage share fell 1.2 pp from 2013 to 2022. Locally, PCN cervical screening is 71.8% (England 66.8%) but fell 2.6% over three years (England -1.0%), with Ormskirk Medical Practice at 68.0%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Liverpool University Hospitals NHS Foundation Trust achieved 73.3% on the 62-day referral to treatment standard (standard 85.0%), trailing Mersey and West Lancashire Teaching Hospitals NHS Trust (78.0%), Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust (76.8%), and the ICB (73.6%), though above England (71.2%). On the 28-day faster diagnosis standard, the trust reached 75.5% (standard 75.0%), behind the ICB (78.4%) and England (79.3%). For diagnostics, 33.1% of colonoscopy and 46.5% of flexi sigmoidoscopy patients at the trust waited 6+ weeks, exceeding England (30.8% and 32.1%).

    Pathways within standard (%)LiverpoolMersey and West LancashireWrightington, Wigan and LeighLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)75.4772.3982.8078.3979.32
    31-day treatment (96%)90.5195.4689.0493.6292.50
    62-day referral to treatment (85%)73.2677.9676.7873.6271.16
    Diagnostic waits over 6 weeks (%)LiverpoolMersey and West LancashireWrightington, Wigan and LeighEngland
    MRI6.4214.040.4921.40
    CT0.7113.087.789.92
    Echocardiography12.5534.8824.3728.48
    Colonoscopy33.1418.046.1030.83
    Gastroscopy44.9918.1712.5429.02
    All 15 DM01 tests11.5021.1714.3623.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In June 2026, adults aged 65 and over accounted for 56.9% of all community service contacts among West Lancashire residents (72,000 of 126,445 contacts). This older-age concentration is consistent with borough-wide community care reliance, though activity is published for local authority residents rather than registered PCN cohorts.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice vaccination achievement spans 36.3 pp and overall patient experience spans 20.9 pp

    In 2025/26, QOF overall achievement was 87.6% at Ormskirk Medical Practice. QOF overall achievement was 97.3% at Parkgate Surgery. The England comparator for QOF overall achievement was 92.5%. For QOF vaccination and immunisation-domain achievement, Aughton Surgery achieved 48.8%. In the same domain, Ormskirk Medical Practice achieved 85.1%. The England comparator for vaccination and immunisation achievement was 55.2%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Aughton Surgery1050.072.7%70.6%92.8%
    The Elms Practice1050.071.9%64.1%90.7%
    Ormskirk Medical1370.057.2%70.2%80.7%
    Parkgate Surgery1220.065.5%76.2%71.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWest LancashireAssetPCNWest Lancashire
    Care homes (catchment)13 (652 beds)n/aSchools (catchment)36n/a
    Children's centres17Places of worship2279
    Libraries14Primary schools (LA maintained)1647
    Primary academiesn/a5Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall

    Asthma annual review coverage is 63.8% across 2,070 register patients, below 70.0% in West Lancashire and 65.7% in England, leaving about 750 patients without a recorded 12-month review. For discussion: run a single-template asthma recall prioritising patients on repeat inhalers and offering after-school or holiday review slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    SMI physical health check recall

    Across 233 severe mental illness register patients, 12-month blood pressure recording is 77.5% (down 1.1 pp over three years vs England +4.4 pp), trailing West Lancashire (84.9%) and England (83.4%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Hypertension and lipid titration review

    Among 5,383 hypertension patients (17.7%; gap range -737 to +174), treatment to target is 66.3% (West Lancashire 74.1%, England 70.3%) and under-80 control is 61.7% (Ormskirk Medical Practice 53.1%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register validation (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Severe mental illness check recall (p3)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    SMI physical health recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension titration recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Infant immunisation call and recall (p6)6-in-1 coverage at 12 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice access and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · SMI physical health check recall (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN & Practice
    Option 3 · Hypertension and lipid titration review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15